Trial Profile
Safety profile evaluation of TICagrelor Alone compared to a combination of lysine acetylsalicylate - Clopidogrel in the context of Transcatheter Aortic Valve Implantation (TAVI)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Feb 2022
Price :
$35
*
At a glance
- Drugs Ticagrelor (Primary) ; Clopidogrel; Lysine acetylsalicylate
- Indications Aortic valve stenosis
- Focus Adverse reactions
- Acronyms TICTAVI
- 08 Feb 2022 Status changed from recruiting to completed.
- 02 Feb 2019 This study has been completed in France, according to European Clinical Trials Database record.
- 09 Mar 2016 New trial record